Phase I single and multiple dose escalation trial of PRC 4016 in volunteers.

Trial Profile

Phase I single and multiple dose escalation trial of PRC 4016 in volunteers.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 14 Nov 2012

At a glance

  • Drugs Icosabutate (Primary)
  • Indications Dyslipidaemias
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 14 Nov 2012 Status changed from recruiting to active, no longer recruiting based on information reported in a Pronova BioPharma media release
    • 14 Nov 2012 The study will be finalised during the fourth quarter of 2012, according to a Pronova BioPharma media release.
    • 19 Sep 2011 Status changed from planning to recruiting, according to a Pronova BioPharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top